AGP Picks
View all

Brunei Industry Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Brunei Industry Today.

Press releases published on November 9, 2026

Abcourt obtient les autorisations nécessaires pour commencer les travaux de forage sur la propriété Malartic, détenue en coentreprise avec DPM Metals
Kite Expands Rapidly Across Connecticut, Bringing Its Intentional Cannabis Products to 26 Retail Locations
GoldInxs CEO Issues Letter to Shareholders, Highlights Progression of Maiden Drill Program at Fishpot Project
CECO Environmental Reports Third Quarter 2026 Results
Electra Reports Third Quarter 2026 Results as It Builds North America’s Battery-Grade Cobalt Refinery
CorMedix Therapeutics to Acquire Substantially All Assets of Heron Therapeutics, Expanding Its Portfolio of Products Used in Institutional Settings of Care
Alternative Ballistics Provides Corporate Update Highlighting Commercialization Momentum and Expanding Distribution Network
Solaris Receives Final US$50 Million Tranche Under Royal Gold Funding Package
CNH Industrial N.V. Reports Third Quarter 2026 Results
Abeona Therapeutics® Acquires Phase 3-Ready APT-1011, Now ABO-801, and Enters Into Agreement for $30 Million Private Placement
Costamare Bulkers Holdings Limited Sets the Date for Its Third Quarter 2026 Results Release
Solera Expands Global Circularity Consortium into Latin America to Unlock New Economic Opportunities Across the Automotive Ecosystem
Biodesix to Showcase MRD Strategy at the Association for Molecular Pathology (AMP) 2026 Annual Meeting
CHUCK E. CHEESE MAKES HOLIDAY GIFTING ABOUT LESS STUFF, MORE MEMORIES
Codexis Advances ECO Synthesis Toward Adoption Readiness with Quality at Scale and Expanded siRNA Manufacturing Capabilities
Concorde International Group Ltd. (NASDAQ: CIGL) Enters Strategic Letters of Intent to Expand Security Platform into Malaysia
Barrick Reports Third Quarter 2026 Results
Barrick Declares Q3 Dividend
Epitopea Announces First Patient Dosed in OVACT Phase 1/1b Clinical Trial of CryptiVax™-1001 in Advanced High-Grade Serous Ovarian Cancer  
Epitopea annonce l'administration de la première dose à une patiente dans le cadre de l'essai clinique OVACT de phase 1/1b portant sur le CryptiVaxTM-1001 dans le cancer de l'ovaire séreux de haut grade avancé  

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Brunei Industry Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.